Agios Pharmaceuticals, Inc.
AGIO· Nasdaq
AGIOAgios Pharmaceuticals, Inc.
Quarterly figures for Agios Pharmaceuticals, Inc., with source filings when available.
58 quarters. Mar 31, 2012 to Jun 30, 2026. USD.
Agios Pharmaceuticals, Inc. has filed its 10-Q within 29 to 32 days of period end across its last 8 quarters. The 10-K runs 43 to 56 days.
Agios Pharmaceuticals, Inc. · CIK 1439222 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Jul 30, 2026 · pre-market | Jul 30, 2026 | 30 d | 10-Q | $44.75M | +259.3% | -$1.69 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| Apr 29, 2026 · pre-market |
| Apr 29, 2026 |
| 29 d |
| 10-Q |
| $20.75M |
| +137.7% |
| -$1.69 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Feb 12, 2026 · pre-market | Feb 12, 2026 | 43 d | 10-K | $19.97M | +86.1% | — | |
| Q3 2025 | Sep 30, 2025 | Oct 30, 2025 · pre-market | Oct 30, 2025 | 30 d | 10-Q | $12.88M | +43.7% | -$1.78 | |
| Q2 2025 | Jun 30, 2025 | Jul 31, 2025 · pre-market | Jul 31, 2025 | 31 d | 10-Q | $12.46M | +44.6% | -$1.93 | |
| Q1 2025 | Mar 31, 2025 | May 1, 2025 · pre-market | May 1, 2025 | 31 d | 10-Q | $8.73M | +6.6% | -$1.55 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Feb 13, 2025 · pre-market | Feb 13, 2025 | 44 d | 10-K | $10.73M | +51.1% | — | |
| Q3 2024 | Sep 30, 2024 | Oct 31, 2024 · pre-market | Oct 31, 2024 | 31 d | 10-Q | $8.96M | +21.2% | $16.22 | |
| Q2 2024 | Jun 30, 2024 | Aug 1, 2024 · pre-market | Aug 1, 2024 | 32 d | 10-Q | $8.62M | +28.4% | -$1.69 | |
| Q1 2024 | Mar 31, 2024 | May 2, 2024 · pre-market | May 2, 2024 | 32 d | 10-Q | $8.19M | +46.0% | -$1.45 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 15, 2024 · pre-market | Feb 15, 2024 | 46 d | 10-K | $7.10M | +64.8% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 2, 2023 · pre-market | Nov 2, 2023 | 33 d | 10-Q | $7.40M | +110.4% | -$1.64 | |
| Q2 2023 | Jun 30, 2023 | Aug 3, 2023 · pre-market | Aug 3, 2023 | 34 d | 10-Q | $6.71M | +20.2% | -$1.51 | |
| Q1 2023 | Mar 31, 2023 | May 4, 2023 · pre-market | May 4, 2023 | 34 d | 10-Q | $5.61M | +574.2% | -$1.47 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Feb 23, 2023 · pre-market | Feb 23, 2023 | 54 d | 10-K | $4.31M | — | — | |
| Q3 2022 | Sep 30, 2022 | Nov 3, 2022 · pre-market | Nov 3, 2022 | 34 d | 10-Q | $3.52M | — | -$1.49 | |
| Q2 2022 | Jun 30, 2022 | Aug 4, 2022 · pre-market | Aug 4, 2022 | 35 d | 10-Q | $5.58M | — | -$1.68 | |
| Q1 2022 | Mar 31, 2022 | May 5, 2022 · pre-market | May 5, 2022 | 35 d | 10-Q | $832.00K | — | -$1.74 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021 | Dec 31, 2021 | Feb 24, 2022 · pre-market | Feb 24, 2022 | 55 d | 10-K | $0.00 | −100.0% | -$1.74 | |
| Q3 2021 | Sep 30, 2021 | — | Nov 3, 2021 | 34 d | 10-Q | $0.00 | −100.0% | -$1.56 | |
| Q2 2021 | Jun 30, 2021 | — | Jul 29, 2021 | 29 d | 10-Q | $0.00 | −100.0% | -$1.41 | |
| Q1 2021 | Mar 31, 2021 | — | Apr 29, 2021 | 29 d | 10-Q | $0.00 | −100.0% | $26.95 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020 | Dec 31, 2020 | — | Feb 25, 2021 | 56 d | 10-K | $44.05M | +24.3% | -$1.41 | |
| Q3 2020 | Sep 30, 2020 | — | Nov 5, 2020 | 36 d | 10-Q | $34.71M | +33.4% | -$1.43 | |
| Q2 2020 | Jun 30, 2020 | — | Jul 30, 2020 | 30 d | 10-Q | $37.35M | +42.4% | -$1.31 | |
| Q1 2020 | Mar 31, 2020 | — | Apr 30, 2020 | 30 d | 10-Q | $87.10M | +188.1% | -$0.59 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | — | Feb 19, 2020 | 50 d | 10-K | $35.44M | +18.1% | -$1.60 | |
| Q3 2019 | Sep 30, 2019 | — | Oct 31, 2019 | 31 d | 10-Q | $26.02M | +71.2% | -$1.81 | |
| Q2 2019 | Jun 30, 2019 | — | Aug 1, 2019 | 32 d | 10-Q | $26.22M | −35.1% | -$1.87 | |
| Q1 2019 | Mar 31, 2019 | — | May 2, 2019 | 32 d | 10-Q | $30.23M | +245.0% | -$1.59 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018 | Dec 31, 2018 | — | Feb 14, 2019 | 45 d | 10-K | $30.01M | +206.3% | -$1.58 | |
| Q3 2018 | Sep 30, 2018 | — | Nov 1, 2018 | 32 d | 10-Q | $15.20M | +33.8% | -$1.63 | |
| Q2 2018 | Jun 30, 2018 | — | Aug 2, 2018 | 33 d | 10-Q | $40.41M | +256.2% | -$1.19 | |
| Q1 2018 | Mar 31, 2018 | — | May 4, 2018 | 34 d | 10-Q | $8.76M | −16.6% | -$1.63 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2017 | Dec 31, 2017 | — | Feb 14, 2018 | 45 d | 10-K | $9.80M | −56.7% | -$1.81 | |
| Q3 2017 | Sep 30, 2017 | — | Nov 1, 2017 | 32 d | 10-Q | $11.36M | +26.4% | -$1.59 | |
| Q2 2017 | Jun 30, 2017 | — | Aug 8, 2017 | 39 d | 10-Q | $11.35M | +62.6% | -$1.78 | |
| Q1 2017 | Mar 31, 2017 | — | May 4, 2017 | 34 d | 10-Q | $10.51M | −66.4% | -$1.56 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2016 | Dec 31, 2016 | — | Feb 16, 2017 | 47 d | 10-K | $22.65M | +264.2% | -$1.34 | |
| Q3 2016 | Sep 30, 2016 | — | Nov 3, 2016 | 34 d | 10-Q | $8.99M | +64.0% | -$1.63 | |
| Q2 2016 | Jun 30, 2016 | — | Aug 8, 2016 | 39 d | 10-Q | $6.98M | −47.2% | -$1.47 | |
| Q1 2016 | Mar 31, 2016 | — | May 9, 2016 | 39 d | 10-Q | $31.28M | −8.5% | -$0.61 | |
| FY 2015 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2015 | Dec 31, 2015 | — | Feb 26, 2016 | 57 d | 10-K | $6.22M | −57.5% | -$1.08 | |
| Q3 2015 | Sep 30, 2015 | — | Nov 6, 2015 | 37 d | 10-Q | $5.48M | −83.8% | -$1.07 | |
| Q2 2015 | Jun 30, 2015 | — | — | — | — | $13.22M | +57.2% | -$0.85 | |
| Q1 2015 | Mar 31, 2015 | — | — | — | — | $34.20M | +306.6% | -$0.13 | |
| FY 2014 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2014 | Dec 31, 2014 | — | — | — | — | $14.64M | +117.0% | -$0.76 | |
| Q3 2014 | Sep 30, 2014 | — | — | — | — | $33.90M | +440.8% | $0.10 | |
| Q2 2014 | Jun 30, 2014 | — | — | — | — | $8.41M | +34.2% | -$0.54 | |
| Q1 2014 | Mar 31, 2014 | — | — | — | — | $8.41M | +34.2% | -$0.39 | |
| FY 2013 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2013 | Dec 31, 2013 | — | — | — | — | $6.74M | +7.4% | -$0.40 | |
| Q3 2013 | Sep 30, 2013 | — | — | — | — | $6.27M | ±0.0% | -$0.52 | |
| Q2 2013 | Jun 30, 2013 | — | — | — | — | $6.27M | −0.3% | -$2.80 | |
| Q1 2013 | Mar 31, 2013 | — | — | — | — | $6.27M | ±0.0% | -$2.47 | |
| FY 2012 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2012 | Dec 31, 2012 | — | — | — | — | $6.28M | — | -$2.09 | |
| Q3 2012 | Sep 30, 2012 | — | — | — | — | $6.27M | — | -$1.87 | |
| Q2 2012 | Jun 30, 2012 | — | — | — | — | $6.29M | — | -$2.18 | |
| Q1 2012 | Mar 31, 2012 | — | — | — | — | $6.27M | — | -$1.98 | |
